460
Views
105
CrossRef citations to date
0
Altmetric
Research Article

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

, , , , &
Pages 97-105 | Received 15 Nov 2005, Accepted 14 Feb 2006, Published online: 08 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (16)

Maryam Sadat Ashrafzadeh, Azim Akbarzadeh, Amir Heydarinasab & Mehdi Ardjmand. (2020) In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin. International Journal of Nanomedicine 15, pages 7035-7049.
Read now
Chiara Ferraris, Roberta Cavalli, Pier Paolo Panciani & Luigi Battaglia. (2020) Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours. International Journal of Nanomedicine 15, pages 2999-3022.
Read now
Giovanni Tosi, J. T. Duskey & Jörg Kreuter. (2020) Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opinion on Drug Delivery 17:1, pages 23-32.
Read now
Laura Cabeza, Raúl Ortiz, José L Arias, Jose Prados, Maria Adolfina Ruiz Martínez, José M Entrena, Raquel Luque & Consolación Melguizo. (2015) Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles. International Journal of Nanomedicine 10, pages 1291-1306.
Read now
Khaled Messaoudi, Patrick Saulnier, Kim Boesen, Jean-Pierre Benoit & Frederic Lagarce. (2014) Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide. International Journal of Nanomedicine 9, pages 1479-1490.
Read now
Hayley Nehoff, Neha N Parayath, Laura Domanovitch, Sebastien Taurin & Khaled Greish. (2014) Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. International Journal of Nanomedicine 9, pages 2539-2555.
Read now
Rong Tan, Mengmeng Niu, Jihui Zhao, Ying Liu & Nianping Feng. (2014) Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting. Journal of Drug Targeting 22:6, pages 509-517.
Read now
Antony Deva Punitha & Anand Kumar Srivastava. (2013) CNS drug targeting: have we travelled in right path?. Journal of Drug Targeting 21:9, pages 787-800.
Read now
Yi-Ting Xie, Yong-Zhong Du, Hong Yuan & Fu-Qiang Hu. (2012) Brain-targeting study of stearic acid–grafted chitosan micelle drug-delivery system. International Journal of Nanomedicine 7, pages 3235-3244.
Read now
Ramya Ranganathan, Shruthilaya Madanmohan, Akila Kesavan, Ganga Baskar, Yoganathan Ramia Krishnamoorthy, Roy Santosham, D Ponraju, Suresh Kumar Rayala & Ganesh Venkatraman. (2012) Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications. International Journal of Nanomedicine 7, pages 1043-1060.
Read now
Thomas M Barchet & Mansoor M Amiji. (2009) Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases. Expert Opinion on Drug Delivery 6:3, pages 211-225.
Read now
Giovanni Tosi, Luca Costantino, Barbara Ruozi, Flavio Forni & Maria Angela Vandelli. (2008) Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opinion on Drug Delivery 5:2, pages 155-174.
Read now
Kamal Krishna Halder, Bivash Mandal, Mita Chatterjee Debnath, Hriday Bera, Lakshmi Kanto Ghosh & Bijon Kumar Gupta. (2008) Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: Formulation, characterization, technetium-99m labeling and biodistribution studies. Journal of Drug Targeting 16:4, pages 311-320.
Read now
Zhiwen Yang, Muhua Yang & Jinnian Peng. (2008) Evaluation of Arsenic Trioxide-Loaded Albumin Nanoparticles as Carriers: Preparation and Antitumor Efficacy. Drug Development and Industrial Pharmacy 34:8, pages 834-839.
Read now
Xingguo Cheng & Liisa Kuhn. (2007) Chemotherapy drug delivery from calcium phosphate nanoparticles. International Journal of Nanomedicine 2:4, pages 667-674.
Read now
Alessandra Ambruosi, Svetlana Gelperina, Alexander Khalansky, Sandra Tanski, Alf Theisen & Jörg Kreuter. (2006) Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. Journal of Microencapsulation 23:5, pages 582-592.
Read now

Articles from other publishers (89)

Mariana Sell, Ana Rita Lopes, Maria Escudeiro, Bruno Esteves, Ana R. Monteiro, Tito Trindade & Luísa Cruz-Lopes. (2023) Application of Nanoparticles in Cancer Treatment: A Concise Review. Nanomaterials 13:21, pages 2887.
Crossref
Chukwuyem Ekhator, Muhammad Qasim Qureshi, Abdul Wasay Zuberi, Muqaddas Hussain, Niraj Sangroula, Sushanth Yerra, Monika Devi, Muhammad Arsal Naseem, Sophia B Bellegarde & Praful R Pendyala. (2023) Advances and Opportunities in Nanoparticle Drug Delivery for Central Nervous System Disorders: A Review of Current Advances. Cureus.
Crossref
D. Sh. Dzhalilova, N. A. Zolotova, V. A. Mkhitarov, A. M. Kosyreva, I. S. Tsvetkov, A. S. Khalansky, A. I. Alekseeva, T. H. Fatkhudinov & O. V. Makarova. (2023) Morphological and molecular-biological features of glioblastoma progression in tolerant and susceptible to hypoxia Wistar rats. Scientific Reports 13:1.
Crossref
Naumih M. Noah, Betty N. Mbatia & Calvin A. Omolo. 2023. Advanced Nanoformulations. Advanced Nanoformulations 685 717 .
Sofia Parrasia, Ildikò Szabò, Mario Zoratti & Lucia Biasutto. (2022) Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges. Molecular Pharmaceutics 19:11, pages 3700-3729.
Crossref
Sukanya Bhunia & Arabinda Chaudhuri. 2022. Brain Tumors. Brain Tumors.
Phoebe McCrorie, Jonathan Rowlinson, David J. Scurr, Maria Marlow & Ruman Rahman. (2022) Detection of Label-Free Drugs within Brain Tissue Using Orbitrap Secondary Ion Mass Spectrometry as a Complement to Neuro-Oncological Drug Delivery. Pharmaceutics 14:3, pages 571.
Crossref
Amin Mehrabian, Mohammad Mashreghi, Saba Dadpour, Ali Badiee, Leila Arabi, Seyedeh Hoda Alavizadeh, Seyedeh Alia Moosavian & Mahmoud Reza Jaafari. (2022) Nanocarriers Call the Last Shot in the Treatment of Brain Cancers. Technology in Cancer Research & Treatment 21, pages 153303382210809.
Crossref
Chhavi Bhalothia & Girima Nagda. (2022) Nanotherapeutics a promising approach for treatment of Parkinson’s disease. Materials Today: Proceedings 69, pages A1-A13.
Crossref
Jyotsna Shankar, Geetha K.M & Barnabas Wilson. (2021) Potential applications of nanomedicine for treating Parkinson's disease. Journal of Drug Delivery Science and Technology 66, pages 102793.
Crossref
Bijuli Rabha, Kaushik Kumar Bharadwaj, Siddhartha Pati, Bhabesh Kumar Choudhury, Tanmay Sarkar, Zulhisyam Abdul Kari, Hisham Atan Edinur, Debabrat Baishya & Leonard Ionut Atanase. (2021) Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update. Polymers 13:23, pages 4114.
Crossref
Xinran Zhang, Li Yin Chau, Ho Wan Chan, Jingwen Weng, Ka Wai Wong, Shing Fung Chow & Albert Hee Lum Chow. (2021) Physical stability and in vivo brain delivery of polymeric ibuprofen nanoparticles fabricated by flash nanoprecipitation. International Journal of Pharmaceutics 598, pages 120224.
Crossref
Faheem Hyder Pottoo, Md. Noushad Javed, Jawad Ur Rahman, Tareq Abu-Izneid & Firdos Alam Khan. (2021) Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme. Seminars in Cancer Biology 69, pages 391-398.
Crossref
Wen Li, Jianhua QiuXiang-Ling LiSezin Aday, Jingdong Zhang, Grace Conley, Jun Xu, John JosephHaoyue LanRobert Langer, Rebekah Mannix, Jeffrey M. Karp & Nitin Joshi. (2021) BBB pathophysiology–independent delivery of siRNA in traumatic brain injury. Science Advances 7:1.
Crossref
Aniket S. Wadajkar, Nina P. Connolly, Christine P. Carney, Pranjali P. Kanvinde, Jeffrey A. Winkles, Graeme F. Woodworth & Anthony J. Kim. 2021. Nanotherapy for Brain Tumor Drug Delivery. Nanotherapy for Brain Tumor Drug Delivery 127 144 .
Kristian Kempe & Joseph A. Nicolazzo. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery 1 27 .
Natascha Hartl, Friederike Adams & Olivia M. Merkel. (2020) From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier. Advanced Therapeutics 4:1, pages 2000092.
Crossref
Laurel O Sillerud, Yirong Yang, Lisa Y Yang, Kelsey B Duval, Jeffrey Thompson & Yi Yang. (2020) Longitudinal monitoring of microglial/macrophage activation in ischemic rat brain using Iba-1-specific nanoparticle-enhanced magnetic resonance imaging. Journal of Cerebral Blood Flow & Metabolism 40:1_suppl, pages S117-S133.
Crossref
Anis Askarizadeh, George E. Barreto, Neil C. Henney, Muhammed Majeed & Amirhossein Sahebkar. (2020) Neuroprotection by curcumin: A review on brain delivery strategies. International Journal of Pharmaceutics 585, pages 119476.
Crossref
Sunita Lahkar & Malay Kumar Das. (2020) Surface-modified polycaprolactone nanoparticles for the brain-targeted delivery of nevirapine. Journal of Nanoparticle Research 22:5.
Crossref
Shahryar Shakeri, Milad Ashrafizadeh, Ali Zarrabi, Rasoul Roghanian, Elham Ghasemipour Afshar, Abbas Pardakhty, Reza Mohammadinejad, Anuj Kumar & Vijay Kumar Thakur. (2020) Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics. Biomedicines 8:1, pages 13.
Crossref
Eduarda Monteiro Fidelis, Anne Suély Pinto Savall, Edina da Luz Abreu, Felipe Carvalho, Flávia Elizabete Guerra Teixeira, Sandra Elisa Haas, Tuane Bazanella Sampaio & Simone Pinton. (2019) Curcumin-Loaded Nanocapsules Reverses the Depressant-Like Behavior and Oxidative Stress Induced by β-Amyloid in Mice. Neuroscience 423, pages 122-130.
Crossref
Olga Maksimenko, Julia Malinovskaya, Elena Shipulo, Nadezhda Osipova, Victoria Razzhivina, Diana Arantseva, Oksana Yarovaya, Ulyana Mostovaya, Alexander Khalansky, Vera Fedoseeva, Anna Alekseeva, Ludmila Vanchugova, Marina Gorshkova, Elena Kovalenko, Vadim Balabanyan, Pavel Melnikov, Vladimir Baklaushev, Vladimir Chekhonin, Jörg Kreuter & Svetlana Gelperina. (2019) Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development. International Journal of Pharmaceutics 572, pages 118733.
Crossref
A. I. Skorobogatova, O. A. Terent’eva, V. A. Vainshtein, S. V. Okovityi, E. V. Flisyuk & I. A. Narkevich. (2019) Targeted Transport as a Promising Method of Drug Delivery to the Central Nervous System (Review). Pharmaceutical Chemistry Journal 53:9, pages 845-851.
Crossref
Rameshwar Patil, Anna Galstyan, Tao Sun, Ekaterina S. Shatalova, Pramod Butte, Adam N. Mamelak, Christine Carico, David S. Kittle, Zachary B. Grodzinski, Antonella Chiechi, Hui Ding, Keith L. Black, Julia Y. Ljubimova & Eggehard Holler. (2019) Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme. Biomaterials 206, pages 146-159.
Crossref
Umbreen Hafeez & Lawrence M Cher. (2019) Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects. Neuro-Oncology Advances 1:1.
Crossref
Majid Saeedi, Masoumeh Eslamifar, Khadijeh Khezri & Solmaz Maleki Dizaj. (2019) Applications of nanotechnology in drug delivery to the central nervous system. Biomedicine & Pharmacotherapy 111, pages 666-675.
Crossref
Georgi Yordanov. 2019. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics 59 79 .
Andrea Joseph, Thomas Wood, Chih-Chung Chen, Kylie Corry, Jessica M. Snyder, Sandra E. Juul, Pratik Parikh & Elizabeth Nance. (2018) Curcumin-loaded polymeric nanoparticles for neuroprotection in neonatal rats with hypoxic-ischemic encephalopathy. Nano Research 11:10, pages 5670-5688.
Crossref
Yingjia Li, Manxiang Wu, Nisi Zhang, Caiyun Tang, Peng Jiang, Xin Liu, Fei Yan & Hairong Zheng. (2018) Mechanisms of enhanced antiglioma efficacy of polysorbate 80‐modified paclitaxel‐loaded PLGA nanoparticles by focused ultrasound. Journal of Cellular and Molecular Medicine 22:9, pages 4171-4182.
Crossref
Samir G. Patel, Meghal D. Patel, Archita J. Patel, Mahavir B. Chougule & Hira Choudhury. 2018. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors 191 244 .
Nandhakumar Sathyamoorthy, Dhanaraju Magharla, Pavankumar Chintamaneni & Sundar Vankayalu. (2017) Optimization of paclitaxel loaded poly (ε-caprolactone) nanoparticles using Box Behnken design. Beni-Suef University Journal of Basic and Applied Sciences 6:4, pages 362-373.
Crossref
Sathyamoorthy Nandhakumar, Magharla Dasaratha Dhanaraju, Vankayalu Devendran Sundar & Battu Heera. (2017) Influence of surface charge on the in vitro protein adsorption and cell cytotoxicity of paclitaxel loaded poly(ε-caprolactone) nanoparticles. Bulletin of Faculty of Pharmacy, Cairo University 55:2, pages 249-258.
Crossref
Taru Dube, Sonika Chibh, Jibanananda Mishra & Jiban Jyoti Panda. (2017) Receptor Targeted Polymeric Nanostructures Capable of Navigating across the Blood-Brain Barrier for Effective Delivery of Neural Therapeutics. ACS Chemical Neuroscience 8:10, pages 2105-2117.
Crossref
Victor M Lu, Kerrie L McDonald & Helen E Townley. (2017) Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma. Nanomedicine 12:19, pages 2389-2401.
Crossref
Aniket S. Wadajkar, Jimena G. Dancy, David S. Hersh, Pavlos Anastasiadis, Nhan L. Tran, Graeme F. Woodworth, Jeffrey A. Winkles & Anthony J. Kim. (2016) Tumor‐targeted nanotherapeutics: overcoming treatment barriers for glioblastoma. WIREs Nanomedicine and Nanobiotechnology 9:4.
Crossref
Mauricio P Pinto, Maximiliano Arce, Basit Yameen & Cristian Vilos. (2017) Targeted brain delivery nanoparticles for malignant gliomas. Nanomedicine 12:1, pages 59-72.
Crossref
David S. Hersh, Aniket S. Wadajkar & Graeme F. Woodworth. 2017. Malignant Brain Tumors. Malignant Brain Tumors 193 216 .
Robert A. Yokel. (2016) Physicochemical properties of engineered nanomaterials that influence their nervous system distribution and effects. Nanomedicine: Nanotechnology, Biology and Medicine 12:7, pages 2081-2093.
Crossref
Antonella Mangraviti, David Gullotti, Betty Tyler & Henry Brem. (2016) Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies. Journal of Controlled Release 240, pages 443-453.
Crossref
Reatul Karim, Claudio Palazzo, Brigitte Evrard & Geraldine Piel. (2016) Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art. Journal of Controlled Release 227, pages 23-37.
Crossref
Yuebin Zhang, Jia Yu, Lifeng Zhang, Jiabin Cai, Doute Cai & Chengjie Lv. (2015) Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles. Tumor Biology 37:2, pages 2703-2708.
Crossref
Georgi Yordanov, Ralica Skrobanska & Milena Petkova. (2016) Poly(butyl cyanoacrylate) nanoparticles stabilised with poloxamer 188: particle size control and cytotoxic effects in cervical carcinoma (HeLa) cells. Chemical Papers 70:3.
Crossref
John Kealy & Matthew Campbell. 2016. Resistance to Targeted Therapies Against Adult Brain Cancers. Resistance to Targeted Therapies Against Adult Brain Cancers 69 87 .
Nolan Ung & Isaac Yang. (2015) Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme. Journal of Neuro-Oncology 123:3, pages 473-481.
Crossref
Bhushan S. Pattni & Vladimir P. Torchilin. 2015. Targeted Drug Delivery : Concepts and Design. Targeted Drug Delivery : Concepts and Design 3 38 .
M. Vera, E. Barcia, S. Negro, P. Marcianes, L. García-García, K. Slowing & A. Fernández-Carballido. (2014) New celecoxib multiparticulate systems to improve glioblastoma treatment. International Journal of Pharmaceutics 473:1-2, pages 518-527.
Crossref
Jörg Kreuter. (2014) Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?. Advanced Drug Delivery Reviews 71, pages 2-14.
Crossref
Sutapa Barua & Samir Mitragotri. (2014) Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects. Nano Today 9:2, pages 223-243.
Crossref
Luciana M. Herda, Ester Polo, Philip M. Kelly, Louise Rocks, Diána Hudecz & Kenneth A. Dawson. (2014) Designing the future of nanomedicine: current barriers to targeted brain therapeutics. European Journal of Nanomedicine 6:3.
Crossref
Mamoru Tanaka, Hiromi Kataoka, Shigenobu Yano, Hiromi Ohi, Keisuke Kawamoto, Takashi Shibahara, Tsutomu Mizoshita, Yoshinori Mori, Satoshi Tanida, Takeshi Kamiya & Takashi Joh. (2013) Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells. BMC Cancer 13:1.
Crossref
Elita F. da Silveira, Janaine M. Chassot, Fernanda C. Teixeira, Juliana H. Azambuja, Gabriela Debom, Fátima T. Beira, Francisco A. B. Del Pino, Adriana Lourenço, Ana P. Horn, Letícia Cruz, Roselia M. Spanevello & Elizandra Braganhol. (2013) Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme. Investigational New Drugs 31:6, pages 1424-1435.
Crossref
Babak Kateb & John HeissJoseph Cheatle & Michele Aizenberg. 2013. The Textbook of Nanoneuroscience and Nanoneurosurgery. The Textbook of Nanoneuroscience and Nanoneurosurgery 381 394 .
Zorka Bedzhova & Georgi Yordanov. (2013) Preparation of epirubicin-loaded poly(butyl cyanoacrylate) colloidal particles by polymerization in a mixed organic–aqueous solvent system. Colloids and Surfaces A: Physicochemical and Engineering Aspects 431, pages 27-33.
Crossref
Georgi Yordanov, Alexander Evangelatov & Ralica Skrobanska. (2013) Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: Preparation and in vitro evaluation in human lung adenocarcinoma cells. Colloids and Surfaces B: Biointerfaces 107, pages 115-123.
Crossref
Brenda Auffinger, Ramin Morshed, Alex Tobias, Yu Cheng, Atique U Ahmed & Maciej S Lesniak. (2013) Drug-Loaded Nanoparticle Systems And Adult Stem Cells: A Potential Marriage For The Treatment Of Malignant Glioma?. Oncotarget 4:3, pages 378-396.
Crossref
Joseph D Meyers, Tennyson Doane, Clemens Burda & James P Basilion. (2013) Nanoparticles for imaging and treating brain cancer. Nanomedicine 8:1, pages 123-143.
Crossref
ML Pinzón-Daza, R Garzón, PO Couraud, IA Romero, B Weksler, D Ghigo, A Bosia & C Riganti. (2012) The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells . British Journal of Pharmacology 167:7, pages 1431-1447.
Crossref
G Tosi, B Ruozi, L Badiali, L Bondioli, D Belletti, F Forni & M Vandelli. 2012. Nanotechnology in Health Care. Nanotechnology in Health Care 107 168 .
Elizabeth A. NanceGraeme F. WoodworthKurt A. SailorTing-Yu ShihQingguo XuGanesh SwaminathanDennis XiangCharles EberhartJustin Hanes. (2012) A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue. Science Translational Medicine 4:149.
Crossref
Stefanie Wohlfart, Svetlana Gelperina & Jörg Kreuter. (2012) Transport of drugs across the blood–brain barrier by nanoparticles. Journal of Controlled Release 161:2, pages 264-273.
Crossref
Luca Costantino & Diana Boraschi. (2012) Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?. Drug Discovery Today 17:7-8, pages 367-378.
Crossref
Francine R. Ianiski, Catiane B. Alves, Ana Cristina G. Souza, Simone Pinton, Silvane S. Roman, Cristiano R.B. Rhoden, Marta P. Alves & Cristiane Luchese. (2012) Protective effect of meloxicam-loaded nanocapsules against amyloid-β peptide-induced damage in mice. Behavioural Brain Research 230:1, pages 100-107.
Crossref
Giovanni TosiLuca Badiali, Barbara RuoziAnna Valeria Vergoni, Lucia BondioliAnna Ferrari, Francesco Rivasi, Flavio ForniMaria Angela Vandelli. (2012) Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?. Nanomedicine 7:3, pages 365-382.
Crossref
Yeong Shin Yim, Jin-sil Choi, Gun Tae Kim, Chul Hoon Kim, Tae-Hyun Shin, Dong Goo Kim & Jinwoo Cheon. (2012) A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood–brain barrier (BBB). Chem. Commun. 48:1, pages 61-63.
Crossref
Stefanie Wohlfart, Alexander S. Khalansky, Svetlana Gelperina, David Begley & Jörg Kreuter. (2011) Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier. Journal of Controlled Release 154:1, pages 103-107.
Crossref
V. Bojat, D. S. Baranov, E. A. Oganesyan, Y. M. Hamdy, V. Yu. Balaban’yan & R. N. Alyautdin. (2011) Cytotoxic Effect of Paclitaxel Incorporated in Nanoparticles Based on Lactic and Glycolic Acid Copolymer. Bulletin of Experimental Biology and Medicine 151:3, pages 340-343.
Crossref
Stefanie Wohlfart, Alexander S. Khalansky, Svetlana Gelperina, Olga Maksimenko, Christian Bernreuther, Markus Glatzel & Jörg Kreuter. (2011) Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers. PLoS ONE 6:5, pages e19121.
Crossref
Mathilde Roger, Anne Clavreul, Marie-Claire Venier-Julienne, Catherine Passirani, Claudia Montero-Menei & Philippe Menei. (2011) The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. Biomaterials 32:8, pages 2106-2116.
Crossref
Pengcheng Zhang, Luojuan Hu, Yucai Wang, Jun Wang, Linyin Feng & Yaping Li. (2010) Poly(ε-caprolactone)-Block-poly(ethyl Ethylene Phosphate) Micelles for Brain-Targeting Drug Delivery: In Vitro and In Vivo Valuation. Pharmaceutical Research 27:12, pages 2657-2669.
Crossref
Luca Costantino. (2010) Drug delivery to the CNS and polymeric nanoparticulate carriers. Future Medicinal Chemistry 2:11, pages 1681-1701.
Crossref
Wei-hua Ren, Jiang Chang, Cheng-hu Yan, Xiao-min Qian, Li-xia Long, Bin He, Xu-bo Yuan, Chun-sheng Kang, Didier Betbeder, Jing Sheng & Pei-yu Pu. (2010) Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma. Journal of Materials Science: Materials in Medicine 21:9, pages 2673-2681.
Crossref
Hyun Ryoung Kim, Karine Andrieux & Patrick Couvreur. 2010. Colloid Stability. Colloid Stability 409 428 .
Clemens K. Weiss & Katharina Landfester. 2010. Hybrid Latex Particles. Hybrid Latex Particles 185 236 .
Anna Valeria Vergoni, Giovanni Tosi, Raffaella Tacchi, Maria Angela Vandelli, Alfio Bertolini & Luca Costantino. (2009) Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. Nanomedicine: Nanotechnology, Biology and Medicine 5:4, pages 369-377.
Crossref
Angela R. Jones & Eric V. Shusta. 2009. Therapeutic Monoclonal Antibodies. Therapeutic Monoclonal Antibodies 483 502 .
Jiang Chang, Youssef Jallouli, Maya Kroubi, Xu-bo Yuan, Wei Feng, Chun-sheng Kang, Pei-yu Pu & Didier Betbeder. (2009) Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood–brain barrier. International Journal of Pharmaceutics 379:2, pages 285-292.
Crossref
Karine Andrieux & Patrick Couvreur. (2009) Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 1:5, pages 463-474.
Crossref
Andressa Bernardi, Elizandra Braganhol, Eliézer Jäger, Fabrício Figueiró, Maria Isabel Edelweiss, Adriana R. Pohlmann, Sílvia S. Guterres & Ana M.O. Battastini. (2009) Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Cancer Letters 281:1, pages 53-63.
Crossref
Andrea M. Brioschi, Sara Calderoni, Gian Paolo Zara, Lorenzo Priano, Maria Rosa Gasco & Alessandro Mauro. 2009. Nanoneuroscience and Nanoneuropharmacology. Nanoneuroscience and Nanoneuropharmacology 193 223 .
Luca Costantino, Giovanni Tosi, Barbara Ruozi, Lucia Bondioli, Maria Angela Vandelli & Flavio Forni. 2009. Nanoneuroscience and Nanoneuropharmacology. Nanoneuroscience and Nanoneuropharmacology 35 69 .
Clemens K. Weiss, Maria-Verena Kohnle, Katharina Landfester, Thomas Hauk, Dietmar Fischer, Julia Schmitz-Wienke & Volker Mailänder. (2008) The First Step into the Brain: Uptake of NIO-PBCA Nanoparticles by Endothelial Cells in vitro and in vivo, and Direct Evidence for their Blood-Brain Barrier Permeation. ChemMedChem 3:9, pages 1395-1403.
Crossref
Jörg Kreuter & Svetlana Gelperina. (2018) Use of Nanoparticles for Cerebral Cancer. Tumori Journal 94:2, pages 271-277.
Crossref
Arnaud Béduneau, Patrick Saulnier & Jean-Pierre Benoit. (2007) Active targeting of brain tumors using nanocarriers. Biomaterials 28:33, pages 4947-4967.
Crossref
G. Tosi, L. Costantino, F. Rivasi, B. Ruozi, E. Leo, A.V. Vergoni, R. Tacchi, A. Bertolini, M.A. Vandelli & F. Forni. (2007) Targeting the central nervous system: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. Journal of Controlled Release 122:1, pages 1-9.
Crossref
S. Dreis, F. Rothweiler, M. Michaelis, J. CinatlJr.Jr., J. Kreuter & K. Langer. (2007) Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. International Journal of Pharmaceutics 341:1-2, pages 207-214.
Crossref
Angela R. Jones & Eric V. Shusta. (2007) Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation. Pharmaceutical Research 24:9, pages 1759-1771.
Crossref
Hyun Ryoung Kim, Karine Andrieux & Patrick Couvreur. 2007. Colloid Stability and Application in Pharmacy. Colloid Stability and Application in Pharmacy 409 428 .
B. Petri, A. Bootz, A. Khalansky, T. Hekmatara, R. Müller, R. Uhl, J. Kreuter & S. Gelperina. (2007) Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants. Journal of Controlled Release 117:1, pages 51-58.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.